EU releases more than slotxo 300 cases of thromboembolism from COVID vaccine worldwide
However, this is still a very small ratio compared to nearly 900 million doses of the COVID vaccine worldwide after thromboembolic events have been reported, a serious post-exposure adverse reaction. COVID-19 vaccine From four vaccine manufacturers: AstraZeneca, Johnson & Johnson, Pfizer and Moderna.

Recently, the European Medicines Agency (EMA) released statistics of thromboembolism among people who received the COVID-19 vaccine worldwide, indicating that those who received the AstraZeneca vaccine had an adverse reaction. 287, eight Johnson & Johnson vaccinated, 25 Pfizer vaccinated, and five vaccinated with Moderna.


The AstraZeneca vaccine was the first to be addressed by many countries and concerned about an adverse reaction that prompted the international suspension of vaccination temporarily.

Although the European Medicines Agency initially confirmed that there was no indication that the vaccine was linked to the development of thromboembolism in people who received the vaccine. But it has recently issued a new announcement that the vaccine is likely to be linked to the development of thromboembolism.


The European Union's Drug Administration said yesterday it found a link between a vaccine developed by Johnson & Johnson and thromboembolic conditions. He said a warning about thromboembolism should be included in the drug leaflet. Although the cause of such adverse reactions is not yet known.

However, the European Medicines Agency confirmed the benefits of the COVID-19 vaccine. There is still a lot of risk. The rate of thromboembolism is very low compared to all vaccinated people worldwide.